- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Risk Management Manager (Pharmaceutical Industry) | Barcelona Gran Vía | Spain | Development | Development | Research & Development | Feb 09, 2026 |
| (Senior) Regulatory Affairs Manager | Beijing (Beijing) | China | Development | Development | Research & Development | Feb 08, 2026 |
| International Program Regulatory Associate Director (IPRAD) | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 06, 2026 |
| Principal Scientist, Biomarker Assay Development Bench Scientist | Cambridge (USA) | USA | Biomedical Research | Research | Research & Development | Feb 06, 2026 |
| Medical Science Liaison - Radioligand Therapy | Bucuresti | Romania | International | Development | Research & Development | Feb 06, 2026 |
| AD, Cell Therapy Operations Manager - New York / Tri-State | Field Non-Sales (USA) | USA | US | Marketing | Research & Development | Feb 06, 2026 |
| PL Field Medical Lead - Nordeste | Santo Amaro | Brazil | International | Other | Research & Development | Feb 06, 2026 |
| RA CMC Submission Coordinator | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 05, 2026 |
| RA CMC Senior Submission Coordinator | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 05, 2026 |
| Study Director Community Lead | Barcelona Gran Vía | Spain | Development | Development | Research & Development | Feb 05, 2026 |
| Senior Expert - Medical Device Analytical Representative (m/f/d) | Schaftenau | Austria | Development | Development | Research & Development | Feb 05, 2026 |
| Central Monitor | Dublin (NOCC) | Ireland | Development | Development | Research & Development | Feb 05, 2026 |
| Lead Central Monitor | Dublin (NOCC) | Ireland | Development | Development | Research & Development | Feb 05, 2026 |
| Medical Science Liaison (MSL) ONC Heme Chicago IL - Remote | Field Non-Sales (USA) | USA | US | Marketing | Research & Development | Feb 05, 2026 |
| Regional Head CRMA EU | London (The Westworks) | United Kingdom | Development | Development | Research & Development | Feb 05, 2026 |
| Senior Expert Science & Technology (Analytical Chemistry Oligonucleotides) | Basel (City) | Switzerland | Development | Development | Research & Development | Feb 04, 2026 |
| Head of US Risk Management & Product Safety (Risk Evaluation and Mitigation Strategies-REMS) | East Hanover | USA | Development | Development | Research & Development | Feb 04, 2026 |
| Associate Director Medical Writer | Barcelona Gran Vía | Spain | Development | Development | Research & Development | Feb 04, 2026 |
| Medical Scientific Liaison - Immunology | New South Wales (NSW) | Australia | International | Legal | Research & Development | Feb 04, 2026 |
| Medical Advisor | Hong Kong | Hong Kong Special Administrative Region, China | International | Development | Research & Development | Feb 04, 2026 |
| Ontology Designer - Data42 | Hyderabad (Office) | India | Biomedical Research | Research | Research & Development | Feb 04, 2026 |
| Senior Expert Science & Technology I - Material Science | Shanghai (Shanghai) | China | Development | Development | Research & Development | Feb 04, 2026 |
| Field Medical Lead | Jakarta | Indonesia | International | Development | Research & Development | Feb 04, 2026 |
| Associate or Manager, PHAD Japan | Toranomon (NPKK Head Office) | Japan | Development | Development | Research & Development | Feb 03, 2026 |
| Senior Expert Science & Technology | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 03, 2026 |
| Central Monitor | Hyderabad (Office) | India | Development | Development | Research & Development | Feb 03, 2026 |
| Associate Director, Technology & Platforms | Barcelona Gran Vía | Spain | Development | Development | Research & Development | Feb 03, 2026 |
| Associate Director, Regulatory Affairs CMC | Schaftenau | Austria | Development | Development | Research & Development | Feb 03, 2026 |
| Director, Portfolio Scientific Communications | London (The Westworks) | United Kingdom | International | Development | Research & Development | Feb 03, 2026 |
| Senior Manager, Regulatory Affairs CMC | Schaftenau | Austria | Development | Development | Research & Development | Feb 03, 2026 |
| Manager, Regulatory Affairs CMC | Schaftenau | Austria | Development | Development | Research & Development | Feb 03, 2026 |
| Clinical Development Medical Director (CDMD) Neuroscience | London (The Westworks) | United Kingdom | Development | Development | Research & Development | Feb 03, 2026 |
| Medical Science Liaison -BC | Guangzhou (Guangdong Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Changsha (Hunan Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison-CSU | Guangzhou (Guangdong Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Hefei (Anhui Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -Hema | Tianjin (Tianjin) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Tianjin (Tianjin) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Hefei (Anhui Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -Hema | Tianjin (Tianjin) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Tianjin (Tianjin) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Guangzhou (Guangdong Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Changsha (Hunan Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison-CSU | Guangzhou (Guangdong Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Hefei (Anhui Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -Hema | Tianjin (Tianjin) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Tianjin (Tianjin) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Guangzhou (Guangdong Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison -BC | Changsha (Hunan Province) | China | International | Development | Research & Development | Feb 02, 2026 |
| Medical Science Liaison-CSU | Guangzhou (Guangdong Province) | China | International | Development | Research & Development | Feb 02, 2026 |
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting